Jack W. Singer, EVP, Global Medical Affairs at CTI BIOPHARMA CORP (CTIC), sold 15,000 shares at $1.96 ($29K) on 2015-04-24, disclosed to the SEC on 2015-04-27.
Scheduled sale ($29k) by EVP, Global Medical Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.94 | 600 | $1K | 4.0% |
| 2 | $1.95 | 1,100 | $2K | 7.3% |
| 3 | $1.95 | 1,900 | $4K | 12.6% |
| 4 | $1.96 | 3,440 | $7K | 22.9% |
| 5 | $1.96 | 300 | $588 | 2.0% |
| 6 | $1.96 | 1,200 |
| $2K |
| 8.0% |
| 7 | $1.97 | 3,200 | $6K | 21.4% |
| 8 | $1.97 | 60 | $118 | 0.4% |
| 9 | $1.98 | 3,200 | $6K | 21.5% |
| Total | $1.96 avg | 15,000 | $29K | 100% |
| Filing → |
| CTIC | SELL | 2015-12-18 | $18K | — | Filing → |
| CTIC | SELL | 2015-11-30 | $18K | — | Filing → |
| CTIC | SELL | 2015-10-23 | $24K | — | Filing → |